Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

NCT07572240 is registered in ClinicalTrials.gov with Rousselot BVBA as lead sponsor.

NCT NCT07572240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals
Lead sponsor
Rousselot BVBA
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 27, 2026
Completion date
November 30, 2026
Enrollment
72 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, stress